Beijing Fookangren Biopharmaceutical Technology

Beijing Fookangren Biopharmaceutical Technology is a China-based biotechnology company dedicated to the development and commercialization of treatments for metabolic disorders, particularly diabetes. The company leverages biological extraction and purification technologies to produce its flagship Fookangren series, which is marketed for blood glucose management and the prevention of diabetic complications. Recognized as a high-tech enterprise in Beijing, the firm integrates research and development with large-scale manufacturing and a domestic distribution network. Their product portfolio primarily consists of formulations derived from natural sources, positioned at the intersection of traditional medicine and modern biopharmaceutical science.